-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan News
15
2025-03
Protecting Investors: Keyuan in Action | Stay Away from Illegal Stock Recommendations, Refuse Off-Exchange Margin Financing
2025-03-15
11
2025-03
To inspire employees' innovative thinking and empower them toward the goals of improving quality, reducing costs, and boosting efficiency—thereby enhancing the company's overall operational effectiveness—Keyuan Pharmaceutical launched a company-wide proposal improvement campaign in the fourth quarter of 2024. Since the initiative was kicked off, it has received an enthusiastic response from employees, who have actively submitted valuable suggestions tailored to their respective areas of work. These proposals span across multiple dimensions, including production, management, technology, and safety, vividly demonstrating employees' deep insights into the company's development as well as their strong sense of ownership and commitment.
2025-03-11
08
2025-03
The Chinese heritage has left behind a glorious reputation, and women have powerfully upheld half the sky. To celebrate the 2025 International Women's Day on March 8, showcase the remarkable spirit of women, strengthen team cohesion, and foster a positive atmosphere of respect and care for female employees, Keyuan Pharmaceutical (stock code: 301281.SZ) specially organized a fun-filled event that drew enthusiastic participation from all female staff members across the company.
2025-03-08
05
2025-03
Today is Jingzhe—time when all that has been dormant finally breaks through the soil and emerges!
2025-03-05
28
2025-02
To accelerate the digital transformation process within the company and enhance management efficiency and decision-making capabilities, Keyuan Pharmaceutical organized a special training session on "Application of DeepSeek AI Tools" on the 26th. All middle-level and higher-level managers from the company participated in the training.
2025-02-28
18
2025-02
On February 14, the Shanghe Economic Development Zone held its 2024 Annual Economic Work Conference to review regional development achievements and outline key priorities for the upcoming phase. During the meeting, outstanding enterprises and individuals who excelled in 2024 were recognized and honored. Among them, Shandong Keyuan Pharmaceutical Co., Ltd. (hereafter referred to as "Keyuan Pharmaceutical"), celebrated for its exceptional industry contributions and innovative strength, was awarded both the "Outstanding Contribution Award" and the "Science & Technology Talent Award." Additionally, Jiang Hongsheng, Chairman of Keyuan Pharmaceutical, was officially appointed as the development zone's "Investment Promotion Ambassador," highlighting the company's exemplary role as a model for collaborative government-enterprise growth.
2025-02-18
11
2025-02
Celebrate the Lantern Festival with joy and embrace the warmth of togetherness. On February 12, coinciding with the vibrant Lantern Festival, Keyuan Pharmaceutical (stock code: 301281.SZ) grandly hosted a lantern riddle-solving event, enriching employees' cultural lives while strengthening team cohesion and boosting overall happiness. This event beautifully showcased Keyuan Pharmaceutical's profound and distinctive corporate culture, as well as the energetic and optimistic spirit of its dedicated workforce.
2025-02-11
05
2025-02
To further enhance the company’s core competitiveness and fully meet and adapt to market demands, Keyuan Pharmaceutical successfully organized a special meeting on new product introduction and another on improving and upgrading existing products on February 4. The meetings centered around the "One Core, Two Wings, Three Pillars" development strategy, delving into discussions on new product planning and strategies for enhancing current offerings, thereby driving the company toward transformation, upgrading, and high-quality growth.
2025-02-05
04
2025-02
Get our minds back on track, reset, and rise stronger than ever—draw the bow, tighten the strings, and march boldly into the future! In 2025, all employees at Keyuan Pharmaceutical will embrace the mindset of "starting with a decisive battle and sprinting from the very beginning," relentlessly focusing on targets, unwaveringly prioritizing safety, and maintaining strict vigilance over quality. Let’s make a confident first step as we kick off the new year, ready to sound the charge with full enthusiasm and determination!
2025-02-04
24
2025-01
Over the past year, all employees at the Keyuan Pharmaceutical Marketing Center have worked together as one, proactively tackling market challenges by strengthening marketing efforts, optimizing sales channels, and enhancing customer service quality. Looking ahead to our 2025 goals, everyone in the Marketing Center is determined to shift our work style—approaching the market with respect and deepening our understanding of both market dynamics and product trends. We’ll gain a clearer grasp of customer needs and market shifts, enabling us to develop precise marketing strategies, expand our distribution channels, and wholeheartedly deliver a strong start to the first quarter.
2025-01-24
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline